Farther Finance Advisors, LLC Immatics N.V. Put Options Transaction History
Farther Finance Advisors, LLC
- $5 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IMTX
# of Institutions
78Shares Held
90.8MCall Options Held
201KPut Options Held
109K-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.3MShares$118 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY12MShares$77.2 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY10.2MShares$65.3 Million0.55% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$60.2 Million2.22% of portfolio
-
Vestal Point Capital, LP New York, NY7.19MShares$46.2 Million2.32% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $489M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...